Status:
COMPLETED
COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients
Lead Sponsor:
The Christie NHS Foundation Trust
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a 2 part qualitative study involving a questionnaire (part 1) and focus group discussions (part 2). The purpose of the study is to evaluate how patients' attitudes to technology in the oncolo...
Detailed Description
Clinical trial involvement is more resource-intensive than receiving standard of care treatment and often results in more frequent hospital visits for patients. To reduce the risk of patients to COVID...
Eligibility Criteria
Inclusion
- Participants are eligible to be included in the study only if all of the following criteria apply:
- Patients have to be 18 years of age or older.
- Patients have to be currently enrolled on a phase I, II or III cancer related clinical trial within the Christie NHS Foundation Trust
Exclusion
- Participants are excluded from the study if any of the following criteria apply:
- Unable to understand and converse in English for the focus group session.
- Patient not currently involved in a phase I, II or III clinical trial
Key Trial Info
Start Date :
May 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04852809
Start Date
May 18 2021
End Date
March 10 2022
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M20 4BX